Search

everythinglearnresearchcommunity

for

Search:↓

The conversation is about someone noticing hair regrowth after using a scalp massager and considering a hair transplant. People suggest using finasteride or dutasteride, but there's debate on their effectiveness and side effects. Some see progress, while others are skeptical without consistent photo evidence.

Considering exosome stem cell injections for hair loss alongside minoxidil and finasteride. Some suggest trying dutasteride first due to its proven effectiveness.

Minoxidil's effectiveness varies due to genetic differences in the SULT1A1 enzyme, affecting how well it converts to its active form, minoxidil sulfate. Hyper-responders may experience rapid hair growth and increased side effects, such as pericardial effusion, even at low doses.

A 39-year-old male is experiencing hair regrowth after three months using 1mg oral finasteride daily, 5% topical minoxidil twice daily, dermastamping twice a month, and 2% ketoconazole shampoo weekly. He shares progress photos and receives encouragement and advice from others, noting some improvement and considering additional treatments but is limited by budget.

Using 1mg Finasteride and 5% Minoxidil for a year led to significant hair regrowth, despite initial side effects like decreased sex drive, which improved with exercise. Consistency in treatment was highlighted as crucial for success.

A user shared their 15-month hair regrowth progress using finasteride, minoxidil, biotin, increased protein intake, and derma rolling. They also improved their lifestyle by working out, quitting smoking, drinking less, and getting better sleep.

Concerns about CosmeRNA safety mechanisms and potential side effects. Discussion includes comparisons to Fluridil and questions about nanoparticle specificity and siRNA stability.

The user is experiencing increased hair shedding and is concerned about regression despite consistent use of finasteride, minoxidil, and other treatments. The consensus is that this is likely a temporary shedding phase, and adjustments to the dermarolling frequency are suggested.

Concerns about a potential ban on finasteride and dutasteride due to side effects, with users advocating for continued access and informed choice. Alternative treatments like pyrilutamide are also mentioned.

The conversation discusses the potential benefits of creating a hydrophobic version of finasteride to reduce systemic side effects while maintaining scalp health. It compares this idea to fluridil, which is designed to be hydrophobic and has less systemic absorption.